Skip to main content
American Well Corp logo

American Well Corp — Investor Relations & Filings

Ticker · AMWL ISIN · US03044L1052 US Human health and social work activities
Open in API
Filings indexed 739 across all filing types
Latest filing 2022-12-05 Director's Dealing
Country US United States of America
Listing US AMWL

About American Well Corp

https://business.amwell.com/

American Well Corp, operating as Amwell, is a digital care delivery company that provides a comprehensive technology platform to connect and enable providers, payers, and patients. The company's platform supports hybrid care models, integrating virtual and in-person services across the care continuum. Its solutions are designed for a wide range of clinical programs, including primary and specialty care, behavioral health, and chronic condition management. Amwell's technology aims to simplify care experiences by integrating with existing clinical workflows and electronic health records. The platform is engineered to improve access to care, enhance patient engagement, and help healthcare systems and health plans achieve better clinical, financial, and operational outcomes.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2022-12-05 English
FORM 4 SUBMISSION
Director's Dealing
2022-12-05 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. It reports the entry into a material definitive agreement (a Master Services Agreement and related agreements) between American Well Corporation and Elevance Health. The document includes detailed descriptions of the agreements and references exhibits attached to the filing. There are no financial statements or quarterly/yearly financial results presented, nor is this an earnings release or annual report. The content focuses on a material contract agreement, which is typical for a Form 8-K reporting a material definitive agreement. Therefore, the filing type corresponds to a Regulatory Filing (RNS) as a general SEC current report that does not fit other specific categories like earnings release or management report.
2022-12-01 English
10-Q
Interim / Quarterly Report Q3 2022
2022-11-08 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and states that a press release announcing financial results for the fiscal quarter ended September 30, 2022, is furnished as an exhibit. The document itself does not contain detailed financial statements or substantive financial data but rather references a press release. The length is 3538 characters, which is relatively short and consistent with a report announcing or furnishing a press release rather than the full earnings release or quarterly report. According to the rules, such a document is best classified as a Regulatory Filing (RNS) because it is a current report filing referencing a financial results announcement but not containing the full financial data itself. It is not an Earnings Release (ER) because it does not contain the initial announcement text itself but references it as an exhibit. It is not an Interim/Quarterly Report (IR) because it lacks substantive financial data. Therefore, the best classification is Regulatory Filings (RNS).
2022-11-07 English
FORM 4 SUBMISSION
Director's Dealing
2022-11-03 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.